Close Menu
NEW YORK – Chinese precision oncology company Genetron Health has formed a strategic partnership with Beijing InnoCare Pharma Tech (InnoCare) to provide clinical trial genomic testing and companion diagnostic development services for InnoCare's biomarker-driven oncology drug development.
 
Additional details of the agreement were not disclosed.
 
Genetron, based in Beijing, provides comprehensive genomic profiling services for drug research and development.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.